德克萨斯大学奥斯汀分校殷倩课题组诚聘博士后及博士研究生

殷倩博士于2010年在中国科学技术大学获得高分子化学学士学位，师从刘世勇教授；2015年在伊利诺伊大学厄巴纳-香槟分校获得材料科学与工程学博士学位，师从程建军教授；博士毕业后加入斯坦福大学美国科学院院士Mark Davis教授的课题组从事博士后研究。在此期间，她设计生物材料作为新型工具来解决免疫学中的基本问题并开发先进的免疫疗法，从而创建了自己独特的跨学科研究领域。殷倩博士将于2024年1月入职德克萨斯大学奥斯汀分校生物医学工程系担任助理教授开展独立研究。课题组将利用高分子化学、材料科学、纳米技术、系统免疫学和类器官模型等领域的尖端技术来推动癌症免疫疗法和抗病毒疫苗的发展。欢迎有相关背景的本科生，硕士生申请博士学位，和博士生申请博士后职位。具体详情请查看下面的介绍。

Positions for Postdocs and Graduate Students in

Biomaterials for Immunoengineering

Yin Lab, BME, UT Austin

Yin lab@UT Austin

Multiple positions for postdocs and graduate students in the interface of engineering and immunology are available in the laboratory of Dr. Qian Yin in the Department of Biomedical Engineering (BME) at University of Texas at Austin (UT Austin), starting from January 1st, 2024. The research in Yin lab focuses on employing a biomaterials-centric approach to elucidate the key mechanism for potentiating or diversifying the immune responses, and in parallel, to precisely modulate the immune system and create new immunotherapies against cancer and infectious diseases. The lab will leverage cutting-edge technologies in synthetic chemistry, materials science, nanotechnology, systems immunology, and organoid models to advance developments in cancer immunotherapy and anti-viral vaccines. Our ultimate goal is to translate these new technologies and therapies for clinical applications. In Yin lab, we strive to nurture a collaborative, supportive, and inclusive environment where all members enjoy conducting research, sharing their passion for science with others, collaboratively uncovering inspiring discoveries, and actively pursuing career development. Highly motivated candidates with any related background including Chemistry, Bioengineering, Materials Science and Engineering, Chemical engineering, Immunology, and Cancer Biology are encouraged to apply.

Short Bio of Dr. Yin

Dr. Qian Yin will join UT Austin BME as Tenure-Track Assistant Professor in January 2024. She received her B.S. in Polymer Chemistry under the supervision of Prof. Shiyong Liu at University of Science and Technology of China in 2010, and her Ph.D. in Materials Science and Engineering under the supervision of Prof. Jianjun Cheng at University of Illinois at Urbana-Champaign in 2015. During her postdoc training with Prof. Mark Davis at Stanford University, she created her unique interdisciplinary research niche by designing innovative engineering tools to address fundamental questions in immunology and develop advanced immunotherapies. Dr. Yin is the recipient of CPRIT First-Time, Tenure-Track Faculty award, Stanford Cancer Institute Fellowship/Ellie Guardino Research Fund, NCI CCNE-TD Pilot Project award, CRI Lloyd J Old Memorial Fellowship and Irvington Postdoctoral Fellowship, NCI M-CNTC Fellowship, Nadine Barrie Smith Memorial Fellowship, Beckman Institute Graduate Fellowship, 3M Graduate Fellow, and Racheff-Intel Award.

About UT Austin and Austin, TX

UT Austin is a world-renowned institution that stands at the forefront of academic excellence, innovation, and research. It ranks No. 58 in the world (QS World University Rankings 2024) and No. 9 in top public universities in the United States (2024 U.S.News). The Cockrell School of Engineering at UT Austin consistently ranked in the top 10 in the United States. The university offers competitive salaries and benefits, an extensive support network, and above all, an enriching and highly collaborative community. Austin is one of the USA's sunniest and most vibrant cities in which to live and work. The large and growing high-tech hub has further earned it the nickname of being the "Silicon Hills" in the United States.

Apply for a graduate student position

If you are an admitted doctoral student at UT Austin and are interested in our research, please send yourCVandresearch interestdirectly to Dr. Yin at qianyin.utaustin@gmail.com. If you have not been admitted to UT Austin, please first apply for the doctoral programs (https://cockrell.utexas.edu/admissions/graduate). In the meantime, please forward yourCV,research interestand thecontact information of three referencesto Dr. Yin.

Apply for a postdoc position

Interested postdoc candidates please send a letter summarizingprevious research experience and future interests,CV, andcontact information of three professional referencesto Dr. Yin at qianyin.utaustin@gmail.com.

Selected previous publication

1.Yin. Q. #; Luo, W. #; Mallajosyula, V.; Bo, Y.; Guo, J.; Xie, J.; Sun, M.; Verma R.; Li, C.; Constant, C.; Wagar, L.; Li, J.; Sola, E.; Gupta, N.; Wang, C.; Kask, O.; Chen, X.; Yuan, X.; Rao, J.; Chien, Y.; Cheng, J.; Pulendran, B.; Davis, MM. “A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of Influenza and SARS-CoV-2”.Nature Materials, 2023, 22, 380-390.

2.Yin, Q.; Yu, W.; Grzeskowiak, C.; Li, J.; Huang, H.; Guo, J.; Chen, L.; Wang, F.; Zhao, F.; von Boehmer, L.; Metzner, T.; Leppert, J.; Chien, Y-H.; Kuo, C.; Davis, MM. “Nanoparticle-enabled innate immune stimulation activates endogenous tumor infiltrating T cells with broad antigen specificities”,Proceedings of the National Academy of Sciences,2021, 118 (21) e2016168118.

3.Yin, Q.#; Tang, L. #; Tong, R.; Sternberg, R.; Yang, X.; Dobrucki, LW.; Borst, LB.; Kamstock, DA.; Cai, K.; Song, Z.; Helferich, WG.; Cheng, J.; Fan, TM. “Pamidronate Functionalized Doxorubicin-Polylactide Nanoconjugates for Targeted Therapy of Focal Skeletal Malignant Osteolysis”,Proceedings of the National Academy of Sciences, 2016, 113, E4601-4609.

4.Yin, Q.; Yap, FY.; Yin, L.; Ma, L.; Zhou, Q.; Dobrucki, LW.; Fan, TM.; Gaba, RC.; Cheng, J. “Poly(iohexol) Nanoparticles As Constrast Agents for In Vivo X-ray Computed Tomography Imaging”,Journal of American Chemical Society, 2013, 135, 13620–13623.

来源：高分子科学前沿

声明：仅代表作者个人观点，作者水平有限，如有不科学之处，请在下方留言指正！